Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2003
12/04/2003WO2003072703A3 Adenoviral vector with replication-dependent transgene expression
12/04/2003WO2003070981A3 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines
12/04/2003WO2003068201A3 High affinity antibody having a tcr-like specificity and use in detection and treatment
12/04/2003WO2003066823A3 Prevention of transgene escape in genetically modified perennials
12/04/2003WO2003066810A3 Recombinant bovine immunodeficiency virus based gene transfer system
12/04/2003WO2003065870A3 Digital amplification for detection of mismatch repair deficient tumor cells
12/04/2003WO2003064627A3 Chimeric bird from embryonic stem cells
12/04/2003WO2003064596A3 Desaturase genes, enzymes encoded thereby, and uses thereof
12/04/2003WO2003063785A3 Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
12/04/2003WO2003063679A3 Hepatitis e virus clones and methods of their use
12/04/2003WO2003062386A3 Syndecans and angiogenesis
12/04/2003WO2003060468A3 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease
12/04/2003WO2003060096A3 Assay for the detection of factors that modulate the expression of ingap
12/04/2003WO2003057898A8 Methods and materials for modulating p2x2
12/04/2003WO2003057168A3 Cancer-associated epitope
12/04/2003WO2003056297A3 Self-assembling polymers, and materials fabricated therefrom
12/04/2003WO2003054209A3 A method of reducing non-specific amplification in pcr
12/04/2003WO2003054158A3 Rapidly maturing fluorescent proteins and methods for using the same
12/04/2003WO2003052063A3 Simplified eukaryotic nitrate reductase
12/04/2003WO2003050540A3 Flexible method and apparatus for high throughput production and purification of multiple proteins
12/04/2003WO2003050310A3 Methods for the identification of inhibitors of asparagine synthase, 5-aminolevulinate synthase, histidinol-phosphatase, 3-isopropylmalate and threonine synthase as antibiotics
12/04/2003WO2003050281A3 Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity
12/04/2003WO2003049671A3 Functionalized materials and libraries thereof
12/04/2003WO2003048362A3 Suppression of polymeric alleles
12/04/2003WO2003048338A3 Nucleic acid injected into hepatic vein lumen and delivered to primate liver
12/04/2003WO2003048329A3 Chromosomal saturation mutagenesis
12/04/2003WO2003048328A3 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen
12/04/2003WO2003046552A3 Screening method for compounds that modulate neuronal activity
12/04/2003WO2003046141A3 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
12/04/2003WO2003046134A3 Expression of polypeptides in rod outer segment membranes
12/04/2003WO2003045980A3 Glycopeptide remodeling using amidases
12/04/2003WO2003045415A3 Self-assembling p53 peptides as gene delivery vehicles
12/04/2003WO2003044225A3 Profiling of the immune gene repertoire
12/04/2003WO2003043581A3 Composition and method for modulating bar/fxr receptor activity
12/04/2003WO2003040396A3 Polynucleotide and polypeptide sequences of monkey cathepsins
12/04/2003WO2003040171A3 Protein kinase stress-related polypeptides and methods of use in plants
12/04/2003WO2003039523A3 OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
12/04/2003WO2003035894A3 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
12/04/2003WO2003035892A9 Novel methods for introducing molecules into cells and vectors and compositions for use in such methods
12/04/2003WO2003035677A3 Antimicrobial peptides from the venom of the spider cupiennius salei
12/04/2003WO2003035010A3 Thymosin augmentation of genetic immunization
12/04/2003WO2003032920A3 Oligonucleotide modulation of cell adhesion
12/04/2003WO2003031462A3 Nogo receptor-mediated blockade of axonal growth
12/04/2003WO2003030617A3 Antisense modulation of creb expression
12/04/2003WO2003028537A3 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
12/04/2003WO2003026590A3 Biological control of nanoparticles
12/04/2003WO2003026404A3 Ccr6 chemokine receptor disruptions, compositions and methods relating thereto
12/04/2003WO2003026398A3 V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto
12/04/2003WO2003025003A3 Hiv-gag codon-optimised dna vaccines
12/04/2003WO2003024406A3 Nestin-expressing hair follicle stem cells
12/04/2003WO2003022879A3 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them
12/04/2003WO2003021273A3 Diagnosis of carcinomas
12/04/2003WO2003020901A3 Compositions and methods relating to prostate specific genes and proteins
12/04/2003WO2003018798A3 G-protein coupled receptor and dna sequences thereof
12/04/2003WO2003018755A3 Wild-type ras as a cancer therapeutic agent
12/04/2003WO2003017918A3 A method of inducing the formation of neurofibrillary tangles in transgenic animals
12/04/2003WO2003016491A3 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
12/04/2003WO2003014145A3 Peptides that bind to atherosclerotic lesions
12/04/2003WO2003012066A3 Magnesium precipitate hot start method for molecular manipulation of nucleic acids
12/04/2003WO2003012059A3 Antisense modulation of cyclin d2 expression
12/04/2003WO2003008604A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated aceb gene
12/04/2003WO2003008579A3 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby
12/04/2003WO2003008540A3 Abiotic stress responsive polynucleotides and polypeptides
12/04/2003WO2003006996A3 Natural ligand of gpcr chemr23 and uses thereof
12/04/2003WO2003006504A3 Allelic variants of gpr50
12/04/2003WO2003004603A3 Methods of modulating pharmacokinetics of oligonucleotides
12/04/2003WO2003004531A3 Regulation of human somatostatin receptor-like protein
12/04/2003WO2003002746A3 Perv screening method and use thereof
12/04/2003WO2003001876A3 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
12/04/2003WO2003000904A3 Identification and characterization of plant genes
12/04/2003WO2003000897A3 Identification and characterization of phosphate transporter genes
12/04/2003WO2003000880A3 Homoaconitase as a target for fungicides
12/04/2003WO2002102977A3 Characterization of a membrane estrogen receptor
12/04/2003WO2002102310A3 Proteins associated with cell growth, differentiation, and death
12/04/2003WO2002101061A3 Method for obtaining a monocotyledon plant containing a gene of interest free of foreign ancillary sequence
12/04/2003WO2002099112A3 Lipoxygenase overexpression in plants and reduction in plant sensitivity to diseases and attacks from pathogenic organisms
12/04/2003WO2002099068A3 LCES AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/04/2003WO2002097126A3 Method for detecting gram-positive bacteria having a high gc content
12/04/2003WO2002091926A3 Inhibitors of dna methyltransferase isoforms
12/04/2003WO2002090992A3 Screening method
12/04/2003WO2002087507A3 Breast cancer-associated genes and uses thereof
12/04/2003WO2002087499A3 Cells for detection of enteroviruses
12/04/2003WO2002086144A3 Compositions and methods for recombinational cloning of nucleic acid molecules
12/04/2003WO2002086134A3 Buffer solution for electroporation and a method comprising the use of the same
12/04/2003WO2002086090A3 Identification of essential genes of aspegillus fumigatus and methods of use
12/04/2003WO2002083892A3 Mutants of desoxycytidine kinase having extended enzymatic activity
12/04/2003WO2002083887A3 Regulation of human methionine aminopeptidase-like protein
12/04/2003WO2002082077A3 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
12/04/2003WO2002081635A9 Phage display vector, phages encoded thereby, and methods of use thereof
12/04/2003WO2002081626A3 D-hydantoinase from ochrobactrum anthropi
12/04/2003WO2002081519A9 Ifn-thy fusion protein,dna coding therefore,its preparation and application
12/04/2003WO2002081516A3 Narc10 and narc16, programmed cell death-associated molecules and uses thereof
12/04/2003WO2002081510A3 Proteins, polynucleotides encoding them and methods of using the same
12/04/2003WO2002080846A3 Epothilone derivatives and methods for making and using the same
12/04/2003WO2002079471A3 Cholinesterase-anchoring protein, corresponding nucleic acids and their use for preparing medicines
12/04/2003WO2002079468A8 A method of increasing complementarity in a heteroduplex polynucleotide
12/04/2003WO2002077229A3 Cofactors of the liver x receptor alpha and methods of use
12/04/2003WO2002074987A3 Quantitative diagnostic analysis of hypertonia
12/04/2003WO2002074986A3 An early pre-symptomatic prion diagnostic blood test for encephalopathies
12/04/2003WO2002070723A3 Maize peroxidase genes and their use for improving plant disease resistance and stalk strength